| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |